Comparison of real-time polymerase chain reaction and hybridization assays for the detection of Escherichia coli genomic DNA in process samples and pharmaceutical-grade plasmid DNA products

Analytical Biochemistry

Volumn 322, Issue 1, 2003, Pages 127-129

  Martins, S A M ^a   Prazeres, D M F ^a   Cabral, J M S ^a   Monteiro, G A ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI; GENES;

GENOMIC DNA; HYBRIDIZATION ASSAY; IN-PROCESS; PHARMACEUTICAL GRADE PLASMID DNA; REAL TIME POLYMERASE CHAIN REACTIONS;

POLYMERASE CHAIN REACTION;

BACTERIAL DNA; DNA VACCINE; GENOMIC DNA; PLASMID DNA;

ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DRUG PURIFICATION; ESCHERICHIA COLI; INTERMETHOD COMPARISON; MOLECULAR PROBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; VISNA VIRUS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; VISNA VIRUS;

EID: 0141535030     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2003.07.004     Document Type: Article

References (14)

1. Kanarek A.D. DiClemente S.C. A Guide to Good Manufacturing Practice. 2001;D&MD, Westborough, USA.
2. Briggs J., Panfili P.R. Quantitation of DNA and protein impurities in biopharmaceuticals. Anal. Chem. 63:1991;850-859.
3. Riggin A., Davis G.C., Copman T.L. Reassessing the control of residual DNA in biopharmaceuticals. BioPharmacology. October:1996;36-41.
4. Lahijani R., Duhon M., Lusby E., Betita H., Marquet M. Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive PCR and enzyme linked immunosorbent assay. Hum. Gene Ther. 9:1998;1173-1180.
5. Horn N.A., Meek J.A., Budhazi G., Marquet M. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum. Gene Ther. 6:1995;565-573.
6. US Food and Drug Administration, Content and Format of Chemistry Manufacturing and Controls Information and Establishment Description Information for a Vaccine or Related Product, Rockville, MD FDA, 1999.
7. Sofer G. Validation of biotechnology products and processes. Curr. Opin. Biotechnol. 6:1995;230-234.
8. Diogo M.M., Queiroz J.A., Monteiro G.A., Martins S.A.M., Ferreira G.M.N., Prazeres D.M.F. Purification of cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography. Biotechnol. Bioeng. 5:2000;576-583.
9. Gregory A.C., Rigg G.P., Illidge C.M., Matthews R.C. Quantitation of Escherichia coli genomic DNA contamination in recombinant protein preparations by polymerase chain reaction and affinity-based collection. Anal. Biochem. 296:2001;114-121.
10. Vilalta A., Witlow V., Martin T. Real-time determination of Escherichia coli genomic DNA in plasmid preparation. Anal. Biochem. 301:2002;151-153.
11. Smith III G.J., Helf M., Nesbet C., Meek J., Ferre F. Fast and accurate method for quantitating E. coli host-cell DNA contamination in plasmid DNA preparations. BioTechniques. 26:1999;518-526.
12. Mergulhão F.J.M., Kelly A.G., Monteiro G.A., Taipa M.A., Cabral J.M.S. Troubleshooting in gene splicing by overlap extension: A step-wise method. Mol. Biotechnol. 12:1999;285-287.
13. ISO 8466-1, Water quality - Calibration and evaluation of analytical methods and estimation of performance characteristics. Part 1: Statistical evaluation of the linear calibration function, International Organization of Standardization, Genève, 1990.
14. Per S.R., Aversa R.C., Sito A.F. Quantification of residual DNA in biological products. Clin. Chem. 35:1989;1859-1860.